The topic was stopped after scoping, this means the topic will not proceed to a Technology Appraisal
Status Proposed
Process STA 2018
ID number 2691

Project Team

Project lead Michelle Adhemar

Email enquiries


Key events during the development of the guidance:

Date Update
15 February 2021 Proposed. Topic is proposed
30 November 2020 Following the written consultation on the draft remit and scope and discussions at the scoping workshop, NICE compiled a summary of its findings into a report that was discussed at the September 2020 Topic Selection Oversight Panel (TSOP). The report included advice and recommendations to aid the decision-making process as to whether the topic should continue to progress to the evaluation stage in the NICE work programme. The TSOP concluded that an appraisal of nitisinone for treating alkaptonuria would not add value to the NHS and therefore the topic will not progress any further. NICE’s decision not to proceed with the appraisal should have no impact on existing commissioning arrangements for nitisinone.
29 July 2020 (14:00) Scoping workshop
11 June 2020 - 09 July 2020 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance